A disposable bio-nano-chip usuing agarose beads for protein analysis by Du, Nan
RICE UNIVERSITY 
A Disposable Bio-nano-chip using Agarose Beads for Protein 
Analysis 
by 
NanDu 
A THESIS SUBMITTED 
IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE 
Master of Science 
Amina A. Qutub 
Assistant Professor of Bioengineering 
~. ;AJ/ 
Sibani Lisa Biswal 
Assistant Professor of Chemical and 
Bimolecular Engineering 
HOUSTON, TEXAS 
April2011 
Abstract 
A Disposable Bio-nano-chip using Agarose Beads for Protein 
Analysis 
by 
NanDu 
This thesis reports on the fabrication of a disposable bio-nano-chip (BNC), a 
microfluidic device composed of polydimethylsiloxane (PDMS) and thiolene-based 
optical epoxy which is both cost-effective and suitable for high performance 
immunoassays. A novel room temperature (RT) bonding technique was utilized so 
as to achieve irreversible covalent bonding between PDMS and thiolene-based 
epoxy layers, while at the same time being compatible with the insertion of agarose 
ii 
bead sensors, selectively arranged in an array of pyramidal microcavities replicated 
in the thiolene thin film layer. In the sealed device, the bead-supporting epoxy film is 
sandwiched between two PDMS layers comprising of fluidic injection and drain 
channels. The agarose bead sensors used in the device are sensitized with anti-C-
reactive protein (CRP) antibody, and a fluorescent sandwich-type immunoassay was 
run to characterize the performance of this device. Computational fluid dynamics 
(CFD) was used based on the device specifications to model the bead penetration. 
Experimental data revealed analyte penetration ofthe immunocomplex to 10011m 
into the 280J.lm diameter agarose beads, which correlated well with the simulation. 
iii 
A dose response curve was obtained and the linear dynamic range of the assay was 
established over lngfmL to SOng/mL with a limit of detection less than lng/mL. 
iv 
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1. Introduction 
General immunoassays typically require time-consuming procedures, 
expensive instruments, and highly trained technicians. In implementing 
microfabrication techniques, microfluidic technology has shown significant 
potential to decrease analysis time and miniaturize the large, sophisticated 
detection instrumentation (Sia and Kricka 2008; Walt 2005). Microfluidic 
immunoassay systems can target small volumes of biological solutions with highly 
sensitive integrated sensors (Banie et al. 2005). In efforts to develop portable 
prototype sensors used in microfluidic systems, researchers have explored various 
types of functional materials and techniques, such as nitrocellulose paper (Fu et al. 
2010), silver reduction (Sia et al. 2004), encoded particles (Pre~ibon et al. 2007) 
and gel electrophoresis (Mea~her et al. 2008). New signaling strategies, such as 
multi-wavelength microflow cytometer (Golden et al. 2009), and lensless imaging 
(Moon et al. 2009) have also been reported to further miniaturize the entire 
microfluidic systems for point-of-care applications. 
Recently, incorporating functionalized colloidal micro beads into microfluidic 
channels has been reported as a novel miniaturized means to perform immunoassay 
tests (Lim and Zhan~ 2007; Shin et al. 2007). As the physical support for capture 
antibodies (Nolan and Sklar 2002), beads are suitable as sensors for immunoassays. 
First of all, they possess high surface to volume ratios and thus are capable to 
immobilize a large number of capture antibodies. Furthermore, because of the fact 
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that beads are addressable and can be pre-programmed by selective conjugation to 
various probe molecules, bead-based systems are capable of multiplexed assay tests. 
While many groups use solid phase beads, such as polystyrene beads, some groups 
utilize agarose beads (Ali et al. 2003; Christodoulides et al. 2002; Goodey et al. 2001; 
Jokerst et al. 2008; Thompson et al. 2010), because the interior porous structure of 
agarose beads, further contributes to increase the number of capture antibodies, 
and hence antigen antibody interactions (Jokerst et al. 2011). 
However, the optimal strategy to integrate agarose beads in microfluidic 
systems is still not well established yet. As a particular type of gel, agarose beads 
cannot keep their original shapes if immobilized by clamping in two dimension 
structures (Thompson and Bau 2010). Further, agarose beads need to be kept moist 
after preparation to prevent interior pore size degradation upon bead drying (Wong 
2007), and it is not quite clear yet whether this will affect final signal stabilities. 
Moreover, instead of using lateral flow over the top of beads or diffusion driven 
delivery methods, more complex fluidic patterns such as convective flow are 
necessary for analytes to quickly and effectively penetrate into the core of the beads 
to take full advantage of the high avidity and large density of capture antibodies in 
three dimensional porous structures (Jokerst et al. 2011). To overcome these issues, 
several studies have employed anisotropically etched silicon to both physically 
protect beads within dedicated areas of the array and generate convective flow to 
efficiently deliver analytes to the beads (Christodoulides et al. 2007; Christodoulides 
et al. 2005b; Jokerst et al. 2010; Jokerst et al. 2009; Kirby et al. 2004; Li et al. 2005; 
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Sohn et al. 2005). Nevertheless, fabrication issues and cost constraints limit the 
direct use of silicon into practical systems, and new materials and designs are 
needed to optimize agarose bead-based immunoassays in microfluidic systems. 
This paper focuses on the development of a microfluidic design, termed bio-
nano-chip (BNC), composed of PDMS and thiolene-based epoxy, and evaluates its 
performance with a bead-based C-reactive protein (CRP) immunoassay. The low 
cost chip was integrated by permanently and irreversibly bonding PDMS and 
thiolene film at room temperature (RT). The seal-proof chip is disposable and 
potentially free of contamination. These features are expected to accelerate the 
translation of the BNC from the laboratories to point of care applications for global 
public health (Lee et al. 2010; Yager et al. 2006). To characterize the performance of 
new structure, we carried out a sandwich-type immunoassay for CRP, an 
inflammation and cardiac risk biomarker (Christodoulides et al. 2005a). 
2. Materials and methods 
2.1 Materials and Reagents 
Silicon wafers (4in.) were purchased from Nova Electronic Materials 
(Richardson, TX, USA). Photolithography masks were printed on mylar films at 
10,160dpi by Fine Line Imaging (Colorado Springs, Colorado, USA). SUS-3035 
photoresist was obtained from MicroChem (Newton, MA, USA). Sylgard 184 PDMS 
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kits were manufactured by Dow Corning (Midland, Ml, USA) and 10:1 weight ratio 
(pre-polymer to curing agent) was used in this work. Norland optical adhesive 81 
(NOA81) was ordered from Norland Products (Cranbury, NJ, USA). 3-
Aminopropyltriethoxysilane (APTES, 97%) and 2-hydroxyethylmethacrylate 
(HEMA) were received from Sigma-Aldrich. 
Agarose beads were prepared by emulsification of 2% type 1-B agarose 
purchased from Sigma. Briefly, 1g of agarose was stirred and dissolved in 50mL of 
nano-pure water at 60°C. A suspending solution of 10mL of Span85 (Sigma) and 
90mL hexanes was heated to 60°C and stirred at 900rpm. The agarose solution was 
poured into the suspending solution followed by stirring at 900rpm at 59°C for one 
minute. The stirring was then adjusted to 600rpm with heat off to allow the agarose 
to gel to 25°C. Beads were collected, washed with 50/50 mixture of ethanolfwater 
and sorted using a sieve that screens out beads of 250-280~m in diameter, which 
were then glyoxylated to transform the hydroxyl groups to aldehyde groups. 
Rabbit anti-human CRP antibody used both as capture and detection 
antibody, was purchased from Accurate Chemical Corp (Westbury, NY, USA). 
AlexaFluor®488 protein labeling kit from Invitrogen was conjugated to the 
detection antibody following instructions from the manufacturer. CRP antigen was 
from Fitzgerald (Acton, MA, USA), and the Helicobacter pylori antibody conjugated 
on the control beads, was purchased from Meridian Life Science (Memphis, TN, 
USA). Prior to the assay, CRP antigen was diluted with phosphate buffered saline 
(PBS) blocking buffer containing 1 o/o bovine serum albumin (BSA). Secondary 
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detection antibody was diluted with PBS in 0.4% v fv. A 500 mL volume of 
glyoxylated 2% agarose beads were coupled to 9mgfmL polyclonal rabbit anti 
human CRP antibody in a 1.5 mL solution overnight and blocked with tris solution 
for 1hour prior to final wash. Negative control beads were prepared similarly, by 
incubating 2% agarose beads with a polyclonal antibody irrelevant to the CRP target 
and specific to Helicobacter pylori. 
2.2 Instrumentation 
The BNC was placed under a BX2 Olympus microscope, equipped with a 
mercury lamp, a 0.13 NA 4 x UPlanFlair objective, and a FITC filter cube 
(fluoroisothiocyanate, 480 nm excitation, 505 nm long-pass beam splitter dichroic 
mirror, and 535±25 nm emissions). Fluorescent images were captured by a DVC 
1312C CCD camera (Digital Video Camera, Austin, TX, USA). 
Confocal images were acquired on an LSM 510 META laser scanning 
microscope system equipped with a 10xf0.45 Plen-APOCHROMAT objective lens 
from Zeiss (Germany). From the excitation and emission maxima ofthe 
AlexaFluor®488 dye at 495 nm and 519 nm, respectively, the proper configuration 
controls were applied. Argon laser, Lasos Carl Zeiss promenade 10, with output of 
50% was used for excitation at 488nm. Fluorescence emission was detected in the 
interval between 500 nm and 550 nm. 
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2.3 Assay procedure 
In this study, the chip was then structurally and functionally evaluated with 
the completion of a series of assays targeting detection of CRP. Prior to the assay, a 
3x4 microarray of wells on the chip was manually loaded with agarose beads. The 
first three columns on the array were loaded with beads coupled to anti-CRP 
antibody, while the fourth column hosted negative control beads, coupled to an 
irrelevant antibody to CRP antigen. A syringe pump (NE-1000, New Era Pump 
Systems) was employed to deliver the samples and reagents for the assay. After 
exciting the beads at 480nm, the CRP detection beads exhibited green fluorescence 
signals in contrast to the negative counterparts, confirming the specificity of the 
antigen-antibody reactions and negligible non-specific binding within the BNC 
device (Figure 2). 
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Figure 1 (A) Thiolene-based epoxy bead array layer is sandwiched between 
two PDMS microfluidic layers. (B) Each 280J.lm bead rests in a pyramidal pit 
well replicated from anisotropically etched silicon. (C) A higher pressure 
exists at the initial bead column closest to the inlet. (D) Computational fluidic 
dynamics simulations show analyte binding onto the bead array. (E) 
Schematic representation of a sandwiched-type immunoassay on agarose 
beads. Individual agarose beads conjugated on their surface and in their 
interior with a capture antibody are exposed to samples containing the target 
antigen. The unbound antigen is then washed away and a fluorescence-labeled 
detection antibody specific to the antigen is added that provides the 
characteristic signals when bound to the antigen throughout the beads imaged 
with a ceo camera. 
2.4 Data analysis 
The beads were optically excited at 480 nm and resulting images were 
captured by CCD and further processed to quantitate the signals derived from the 
beads. More specifically, custom-built image analysis routines written within the 
ImageJ environment were used to process the captured images and analyze the 
fluorescence data. Each bead in the array as visualized in the green color was 
scanned with a series of line profiles spanning 80% of the bead diameter and the 
average of the maximum obtained for each profile line was recorded into a list. An 
outlier routine rejected measurements outside two standard deviations (SD) from 
the median. The fluorescence signal of a bead was calculated by averaging the 
fluorescence intensity from the remaining measurements. The fluorescence 
intensity of an array was defined as the average of all fluorescent beads of the same 
type (i.e., CRP) and the background was defined as the average of the negative 
control beads. 
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Figure 2 Epi-fluorescence image of bead array at the end of assays 
(10ngfmL). 
2.5 Computational Modeling 
Computational simulations were run in COMSOL 3.5a (Burlington, MA). An 
array of 280 11m beads resting in individual wells was constructed using AutoCAD 
and then imported into COMSOL. Navier-Stokes and Convection and Diffusion 
application modes were added from the Chemical Engineering module. The 
subdomain properties of the beads were loaded from the water library and 
Brinkman's equation was enabled to allow for flow through a 243nm pore size bead 
with 96% porosity. The inlet velocity was set to 80 IlL/min and outlet pressure was 
set to atmospheric pressure. The reaction rate governing the system is given by cAb 
+ cAg <=> cAbAg, where cAb is the loaded antibody concentration, cAg is the 
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delivered analyte concentration, and cAbAg is the coupled analyte-antibody pair. 
The reaction association and dissociation rates are 105 L·moJ-ls-1 and 10-5 s-1 
respectively. The analyte concentration was set to 300ngfmL and antibody 
concentration was 9.01 mg/mL. For simplicity, the loaded antibody and bound pair 
concentrations were normalized to the inlet analyte concentration. Particle image 
velocimetry (PIV) studies on the platform have been conducted to confirm the flow 
profiles from CFD and the flow patterns presented here compare well with those 
obtained from the experimental PIV (data not shown). 
3. Results and Discussions 
3.1 The fabrication of silicon taste-chip 
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Figure 3 (A) Schematic of silicon crystal structure. (B) The wet etching process 
on the (1 0 0) silicon surface. (C) The SEM image of an etched microwell with a 
glass bead sitting inside. 
A typical silicon taste chip as in Figure 3, is made through bulk 
micromachining of silicon using anisotropic etching. Inverted square- based 
pyramid wells are chemically etched in a square arrayed pattern on silicon wafers 
(230-380 IJ.m thick). This design serves as a chamber to contain the beaded sensing 
element while allowing both bottom-illuminated light to be transmitted through the 
bead and fluid to flow perpendicular through the wafer. Furthermore, patterns of 
these wells have been etched to create 3 x 3, 3 x 4, 4 x 5, 5 x 7, or 10 x 10 arrays. 
Although not fully understood (parameters such as atomic lattice packing 
density and attached HzO molecules play an important role), anisotropic etching of 
silicon is characterized with the very highly preferential etching of silicon along the 
(111) surface, allowing the fabrication of microstructures with a great level of 
control. The complete sequence is shown in Figure 2. Briefly, here is the succession 
of steps required for the fabrication 280-IJ.m double-sided polished p-type 4 inches 
single crystal silicon (1 0 0) wafer was deposited with ShN4 using low-pressure 
chemical vapor deposition (LPCVD) techniques. A layer of -1000 A is created by 
reacting ammonia (NH3) and dichlorosilane (SiChHz) gas with a flow rate of 3.5:1, 
i.e., 70:20 cm3 /min, at 830 °C and 200 mtorr. The wafer is then moved to a 
photolithography clean rom environment. The mask layer is removed from one side 
of the silicon substrate by protecting the other side with photoresist and plasma-
etching (CF4 and Oz at 100W) the ShN4layer. This is achieved by reactive ion 
etching (RIE) with a flow rate of 20:1 CF4:0z (80:4 cm3 /min). An etching rate of 
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-1000 A/min is observed with 100 W of radio-frequency power and 50 mtorr of 
pressure. 
The wafer is dipped into a 40% KOH solution at 79 oc for 9 hours in order to 
etch the substrate. This creates the square-based pyramidal wells with an angle of 
54.7° with respect to the surface of the silicon. Once the KOH etch is completed, the 
nitride masking layer is completely removed with plasma etching. 
To get rid of the reflectance from the substrate, the wafer is soaked in 30% 
HzOz solution for 15-20 min to form a thin SiOz layer on the surface of the silicon. 
This improves surface-wetting characteristics. 
3.2 PDMS-Thiolene hybrid chip design and fabrication 
The hybrid chip is composed of three layers (Figure 4). The top and bottom 
PDMS layers contain the injection and drain channels respectively. The channels 
(300 11m wide, 50 11m high) were molded with SUB-2015 and cast into PDMS. The 
middle layer was an optical epoxy film with square pyramidal cavities, where the 
beads were physically constrained. Optically transparent epoxy provides light 
transmission in a wide spectrum range. The low background noise becomes an 
important feature when dealing with complex biological matrices, such as blood and 
saliva. 
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Figure 4 (A) The layout ofthe bio-nano-chip design. (B) The PDMS-
thiolene hybrid chip with a U.S. penny. 
The following steps were taken to achieve the pyramidal holes in the 
thiolene-based epoxy, as in Figure 4(A). First, a 4001-!m-thick silicon wafer with the 
<100> crystal surface orientation was prepared through anisotropic etching, as 
reported previously (Christodoulides et al. 2007), to create square pyramids with 
dimension at the top of 6701-!m and bottom S0 11m as in Figure 4(B). Second, PDMS is 
casted on the silicon master to get a replica with positive features of the square 
pyramids. Then, NOA81 optical liquid adhesive is dispensed on the PDMS surface 
that has positive features and spun at 3.3 g units for 30 sec. The NOA81 chosen in 
this study has relatively low viscosity (300 cps), and therefore it easily spreads to a 
thin film without any air bubbles by spinning. However, because the PDMS surface is 
naturally hydrophobic, the liquid adhesive tends to aggregate together and form 
droplets on its surface, rather than spread out evenly, before spinning we need first 
utilize oxygen plasma (PE-50, Plasma Etch) and 2-hydroxyethyl methacrylate 
14 
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(HEMA) polymer grafting to render its surface permanently hydrophilic (Bodas and 
Khan-Malek 2006). Finally, the composite was exposed in UV light for 1 min 
(Polylux 500, Norland Products). After the UV treatment, the liquid epoxy turns to a 
hard resilient solid film that could be peeled off easily from the PDMS. As displayed 
in Figure4(C), the replication from silicon to epoxy was accurate in terms of the 
square pyramidal shape. The bottom of the pyramid was found to be enlarged by 
about 50 Jlm due to the need to keep the level of epoxy liquid lower than the peak of 
positive PDMS replica after spinning, in order to produce through holes. A single 
piece of PDMS replica could be reused to produce a number of epoxy copies. 
Spin Epoxy on PDMS mold 
UV Exposure 
TM3000_(l425 
Fcfc: e 1, 16, 25uM 
2011/04/12 16:59 ti l ~·150 SOOum 
2 POMS 
Peel the epoxy off PDMS 
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Load the beads 
5 •••• 
Seal the beads chamber 
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Figure 5 (A) Fabrication process of bead holders with the optical epoxy. (1) 
Spreading the epoxy over the PDMS replica of anisotropically etched silicon 
wafer. (2) Curing epoxy under the UV treatment. (3) Taking the PDMS and 
epoxy apart. ( 4) Attaching the bottom of epoxy film to the PDMS layer 
containing the drain. (5) Arranging the beads into the wells by tweezers. (6) 
Sealing the bead array by the PDMS layer containing the sample delivery 
channel. (B) SEM image on a silicon pyramidal cavity. The scale bar is 500JJ.m. 
(C) SEM image on the epoxy cavity replicated from the silicon mold. The scale 
bar is 500J.1m. 
The thiolene based epoxy could be bonded to PDMS by plasma cleaning 
(Hung et al. 2008). However, the general plasma cleaning protocol of 
bonding(Sunkara et al. 2010; Tang and Lee 2010). It takes advantage of the 
irreversible covalent bonding between plasma treated PDMS and the 3-
aminopropyltriethoxysilane (APTES) modified thermoplastic surface (Figure 6). 
Here, we applied a similar technique to the surface of epoxy. First, the surface of 
epoxy was cleaned by oxygen plasma and then soaked in 1% v fv APTES solution for 
30 min and dried with nitrogen. Second, agarose beads conjugated with anti-CRP 
antibodies were loaded into the wells manually with tweezers. Finally, the epoxy 
surface was brought into contact with the plasma cleaned PDMS surface, resulting 
into irreversible covalent bonding at RT. PDMS may not be suitable when agarose 
beads located on its surface. To ensure the polymeric bead structure stability, the 
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protein-derivatized agarose beads need be kept wetted all the time. On one hand, if 
the beads were loaded before plasma cleaning, the vacuum environment would dry 
out the agarose beads and denature the antibodies. On the other hand, if beads were 
loaded after plasma cleaning, the time required to load beads onto the array, would 
make it hard to exploit the best timeframe for bonding to take effect, which is 
immediately after treatment of the epoxy surface. Recently, a new way of bonding 
PDMS to thermoplastics at RT has been reported (Sunkara et al. 2010; Tan~ and Lee 
2010). It takes advantage of the irreversible covalent bonding between plasma 
treated PDMS and the 3-aminopropyltriethoxysilane (APTES) modified 
thermoplastic surface (Figure 6). Here, we applied a similar technique to the surface 
of epoxy. First, the surface of epoxy was cleaned by oxygen plasma and then soaked 
in 1% v fv APTES solution for 30 min and dried with nitrogen. Second, agarose 
beads conjugated with anti-CRP antibodies were loaded into the wells manually 
with tweezers. Finally, the epoxy surface was brought into contact with the plasma 
cleaned PDMS surface, resulting into irreversible covalent bonding at RT. 
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Plasma treated PDMS 
APTES modified NOA 81 
Figure 6 Room temperature bonding between APTES modified epoxy 
and plasma treated PDMS 
3.3 CRP immunoassay within BNC 
The inverted pyramidal microwells within the BNC serve both as reaction 
and analysis chambers. In a typical assay procedure, sample and reagent solutions 
are delivered around and through the beads, and then exit the chip through a drain, 
as illustrated in Figure 1. The microchip architecture largely enhances the mixing 
and reactions between analytes/ detection antibodies and therefore sensitivities 
(Goodey eta!. 2001; Li eta!. 2005). 
The assay procedure was optimized by varying the sample and reagent 
volumes as well as the assay incubation times. Optimal conditions identified for this 
setup included incubation of CRP antigen for 30min at flow rate of 80 IlL/min, 
followed by 30 min incubation wi th AlexaFluor®488-conjugated detection antibody 
18 
also delivered at 80 1J.L/min for 30 min. Following the incubation of detection 
antibody, the chamber and beads contained within were rinsed with PBS at 120 
IJ.L/min for 3 min to remove non-specific binding of reagents. 
The observed small intra-assay bead to bead variations arise from three main 
sources. First, according to the simulation data of computational fluid dynamics, as 
shown in Figurel(C) and (D), there is a minor pressure gradient across the bead 
array, with pressures dropping from the column closest to the inlet to the column 
closest to the outlet. Higher pressure results in more penetrations of both the 
antigen and detecting antibody into the agarose bead matrix, and hence stronger 
signals. Second, within the same column, signals could vary because of the slightly 
different drain sizes below beads, in other words, the bottom hole size of the 
reaction chamber. Drain size is important to the signal of bead since it also affects 
the pressure applied on the bead by creating complex local fluidic fields. In other 
words, both the location of bead in the array and the pressure on the bead could 
play important roles on the detected fluorescence intensity. In our experiments, and 
especially for multiplex experiments we always keep the arrangement of beads 
consistent with respect to analyte groups, and observe great reproducibility. Last, 
while tightly sieved, the agarose bead size distribution still displays a 5% CV (Won~ 
.2..Q.Ql.), contributing to signal variations in our experiments. Because smaller beads 
sit lower in the pyramidal wells than the larger beads, they receive higher pressures 
and therefore show stronger signals. 
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Figure 7 (A) Confocal fluorescence image of a bead after 25ngfmL CRP assays. 
(C) Dose response curve of CRP based on epi-fluorescence data. 
3.4 Signals in agarose beads 
The signal distribution was investigated by taking confocal images on a CRP 
bead at the end of the assay (Figure 7(A)). The PDMS chip was mounted on a glass 
slide and inverted on the stage for imaging from the objective from below. Medial 
slices of the beads in the x-y plane, with a lJ..lm thickness, at a distance of 140 J..lm 
from the top of the bead, were recorded as 8-bit in the green pseudo-color image of 
510x510 pixels. The confocal data showed that signal mainly formed on the 
peripherals of beads and penetrated about 30% to the core of the beads (Figure 8). 
As compared to the solid phase polystyrene beads, where antigen-antibody 
interactions are confined on their 2D microsphere surfaces, the porous agarose 
beads are capable to capture analytes in 3D shells with a thickness of about 100 11m, 
as we have previously demonstrated (Jokerst et al. 2011). 
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Figure 8 Fluorescence intensity profile recorded across the red arrow 
drawn in Figure 3(A). 
3.5 Dose response curve 
To gain a thorough understanding of the behavior of the platform when used 
in the multiplex, a necessary step is to investigate the behavior of array composed of 
identical beads, as to eliminate any possible influence of the differences between 
beads conjugated to different biological entities, with potentially different 
concentrations of capture antibody depending on the analytes, and possible 
interferences due to cross talk between the immunoassays. In Figure 3(B) is 
displayed a dose response curve of CRP, where each data point obtained by 
averaging nine beads for that concentration with error bars shown at ±1xSD. The 
redundancy of beads in the bead array helps acquire higher statistical significance, a 
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necessary requirement in the first investigative stages of any platform created 
through a new fabrication process. The limit of detection (LOD) was calculated at 
1ngfmL, as the mean of the 0 antigen control run ±3xSD. While the physiological 
range for CRP measurements in blood extends to higher concentrations than the 
standards used in the dose response curve (Liu et al. 2010), we are targeting the 
detection of biomarkers in both blood and saliva (Floriano et al. 2009) in our clinical 
studies. As such, further dilutions by several orders of magnitude are often required 
for the more viscous and mucinous oral fluid, making it more strategic in assay 
development steps to target a wide range of lower concentrations. If necessary, a 
larger dynamic range is achieved easily by lowering or increasing the 
concentrations of detection antibody, as well as the exposure time for the CCD 
camera. 
4. Conclusions 
In summary, we have demonstrated the suitability of a cost-effective 
microfabrication methodology based on PDMS and thiolene-based optical epoxy to 
produce a new disposable bio-nano-chip design for lab-on-a-chip immunoassays. In 
this example demonstrated with a CRP immunoassay, analytes penetrated 100 11m 
into the core of 280 IJ.m porous agarose beads and resulted in high sensitivity. 
Moreover, the fabrication process of the bio-nano-chip is repeatable and amenable 
to scale-up, thereby affording applications targeting resource-scarce settings. In 
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addition, the PDMS, a standard material in microfluidics, allows for a wide range of 
integration with new features and advances, which are constantly emerging from 
the microfluidic. 
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